Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
DIRTT Announces Employment Extensions for Executive Chairman and Chief Transformation Officer
-
GuideAI Health Corp. Engages Market Maker
-
Seer Announces Receipt of Unsolicited Acquisition Proposal from Omid Farokhzad, M.D.
-
Canadian Malartic – Barnat Pit Update
-
Kinross to announce Q2 results on July 29, 2026
-
SBA, USDA Sign MOU to Combat Lawfare Against Farmers, Ranchers, and Small Businesses
-
ITG, Inc. Announces Closing of Initial Public Offering
-
Foundation Academies’ ‘Men Without Shoes’ Exhibition on Black Revolutionary War Soldiers Kicks Off Regional Tour
-
Important Notice to Long-Term Shareholders of First Solar, Inc. (NASDAQ: FSLR); Hub Group, Inc. (NASDAQ: HUBG); Navan, Inc. (NASDAQ: NAVN); and ZoomInfo Technologies, Inc. (NASDAQ: GTM): Grabar Law Of
-
Redwood Living, Inc. Recognized with Three 2026 Top Workplaces Honors
-
Mullen Group Ltd. 2026 Second Quarter Earnings Conference Call and Webcast
-
Mobia Medical Announces Vivistim® Procedure Remains Assigned to New Technology APC 1580 under CMS Proposed 2027 Hospital Outpatient Prospective Payment System Rule
-
Capstone Infrastructure Corporation Provides Notice of Dividend Rates on Cumulative 5-Year Rate Reset Preferred Shares, Series A and Cumulative Floating Rate Preferred Shares, Series B
-
Ethos to Announce Second Quarter 2026 Financial Results on August 3, 2026
-
Fortis Inc. to Hold Teleconference and Webcast on July 31 to Discuss Second Quarter 2026 Results
-
American Indian College Fund Welcomes Six New Members and Student Representatives to the Board of Trustees
-
Business First Bancshares, Inc. Schedules Q2 2026 Earnings Release and Conference Call for July 23
-
Range Announces Conference Call to Discuss Second Quarter 2026 Financial Results
-
Kite Realty Group to Report Second Quarter 2026 Financial Results on July 30, 2026
-
Monthly information on share capital and company voting rights
-
Capital Power to release second quarter 2026 results on July 29
-
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Latin Metals Reports AGM Results
-
Monarch Casino & Resort To Report 2026 Second Quarter Results After Market Close On July 20
-
Kite Realty Group Announces Closing of Offering of 3.25% Exchangeable Senior Notes due 2032
-
Kite Realty Group Announces Closing of Offering of 3.25% Exchangeable Senior Notes due 2032
-
Piedmont Realty Trust, Inc. to Report Second Quarter 2026 Financial Results
-
PennantPark Investment Corporation Announces Monthly Distribution of $0.08 per Share
-
Covenant Logistics Group, Inc. Announces Timing of Second Quarter Earnings Release and Conference Call
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.0833 per Share
-
Spyre Therapeutics Announces Grants of Inducement Awards
-
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Rush Enterprises, Inc. Conference Call Advisory for Second Quarter 2026 Earnings Call
-
Merit Medical Systems to Announce Second Quarter 2026 Results on July 30, 2026
-
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
CapsoVision Appoints Gastroenterology Leader David S. Shields, M.D., to Board of Directors
-
Patria Investments successfully raises over USD 670m for its Secondary Opportunities Fund V
-
vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Robinhood Markets, Inc. to Announce Second Quarter 2026 Results on July 29, 2026
-
Outset Medical Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
-
Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Inhibikase Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
-
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Results of the Votes of the Combined Shareholders’ General Meeting of June 30, 2026

